新検索ページはこちら
ログイン
お問い合わせ
（旧版）高血圧治療ガイドライン2004
書誌情報
文献
| 301 ） | Iimura O: Insulin resistance and hypertension in Japanese. Hypertens Res 1996; 19（Suppl I）: S1-S8. |
| 302 ） | American Diabetes Association: Treatment of hypertension in adults with diabetes. Diabetes Care 2002; 25（Suppl 1）: S71-S73. |
| 303 ） | UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713-720. |
| 304 ） | Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581. |
| 305 ） | 中村陽介，斎藤重幸，高木覚，磯部健，竹内宏，千葉雄，加藤伸郎，藤原禎，赤坂憲，島本和明：耐糖能異常合併と血圧レベル別の心血管疾患死亡．医学のあゆみ 2004; 210: 717-718. |
| 306 ） | Iimura O, Shimamoto K, Matsuda K, Masuda A, Takizawa H, Higashiura K, Miyazaki Y, Hirata A, Ura N, Nakagawa M: Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 1995; 8: 353-357. |
| 307 ） | The EUCLID Study Group: Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792. |
| 308 ） | Viberti G, Wheeldon NM, for the Micro Albuminuria Reduction with VALsartan（MARVAL）Study Investigators. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus. A blood pressure-independent effect. Circulation 2002; 106: 672-678. |
| 309 ） | Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE: Effect of angiotensin converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project（CAPPP）randomised trial. Lancet 1999; 353: 611-616. |
| 310 ） | Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher E, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension: N Engl J Med 1999; 340: 677-684. |
| 311 ） | Estacio RO, Jeffers BM, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared to enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-652. |
| 312 ） | Tatti P, Pahor M, Byington RP, DiMauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial（FACET）in patients with hypertension and NIDDM. Diabetes Care 1998; 21: 597-603. |
| 313 ） | Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia -Primary prevention cohort study of the Japan lipid intervention trial（J-LIT）. Circ J 2002; 66: 1087-1095. |
| 314 ） | Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-Lipid lowering arm（ASCOT-LLA）: a multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158. |
| 315 ） | 厚生省保健医療局健康増進栄養課（監修）：国民栄養の現状．平成2年度国民栄養調査成績．第一出版，東京，1992, p121. |
| 316 ） | Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the national cholesterol education program（NCEP）expert panel on detection, evaluation, and treatment of high blood cholesterol in adults（adult treatment panel III）. JAMA 2001; 285: 2486-2497. |
| 317 ） | Tanaka H, Teramoto S, Oashi K, Saikai T, Tanaka S, Suzuki K, Hashimoto M, Abe S: Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. Circulation 2001; 104: 281-285. |
| 318 ） | Kiely DG, Cargill RI, Lipworth BJ: Effects of frusemide and hypoxia on the pulmonary vascular bed in man. Br J Clin Pharmacol 1997; 43: 309-313. |
| 319 ） | Fang J, Alderman MH: Serum uric acid and cardiovascular mortality. JAMA 2000; 283: 2404-2410. |
| 320 ） | Alderman MH, Cohen H, Madhaven S, Kivlighn S: Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-150. |
| 321 ） | Choi HK, Atkinson K, Karlson EW, Whillett W, Curhan G: Alcohol intake and risk of incident gout in men: a prospective study. JAMA 2004; 363: 1277-1281. |
| 322 ） | Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB: Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program. J Hypertens 2000; 18: 1149-1154. |
| 323 ） | Yamanaka H, Togashi R, Hakoda M, Terai C, Kashiwazaki S, Dan T, Kamatani N: Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment. Adv Exp Med Biol 1998; 431: 13-18. |
| 324 ） | 治療ガイドライン作成委員会，日本痛風・核酸代謝学会：高血圧，心血管障害．高尿酸血症・痛風の治療ガイドライン（第1版）．日本痛風･核酸代謝学会，東京，2002, pp51-55. |
| 325 ） | Cheng JW, Zhu L, Gu MJ, Song ZM: Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients. World J Gastroenterol 2003; 9: 1836-1839. |
| 326 ） | 厚生統計協会：健康状態と受療状況，生活習慣病対策. 国民衛生の動向・厚生の指標（臨時増刊）1998; 45: 81-111. |
| 327 ） | National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension 1994; 23: 275-285. |
| 328 ） | Madhavan S, Ooi WL, Cohen H, Alderman MH: Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401. |
| 329 ） | Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C: Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-988. |
| 330 ） | Imai C, Muratani H, Kimura Y, Kanzato N, Takishita S, Fukiyama K: Effect of meal ingestion and active standing on blood pressure in patients ≧ 60years of age. Am J Cardiol 1998; 81: 1310-1314. |
| 331 ） | Kannel WB, D'Agostino RB, Silbershatz H: Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 1997; 134: 758-763. |
| 332 ） | Port S, Demer L, Jennrich R, Walter D, Garfinkel A: Systolic blood pressure and mortality. Lancet 2000; 355: 175-180. |
| 333 ） | 早川岳人，喜多義邦，岡村智教，門脇崇，上島弘嗣：循環器：循環器疾患死亡とADL低下予防における血圧管理の重要性-NIPPON DATAより-．最新医学 2002; 57: 1360-1368. |
| 334 ） | 高木覚，斉藤重幸，坂本賢一，高橋弘，仲野昌弘，林義人，島本和明：高齢者高血圧の脳・心血管合併症と長期予後-北海道循環器疫学調査の成績より-．血圧 1995; 5: 42-47. |
| 335 ） | Shimada K, Kawano A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T: Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875-878. |
| 336 ） | Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion J-M: Cardiovascular prognosis of ﾒmasked hypertensionﾓ detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349. |
| 337 ） | Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De-Schaepdryver A, Dollery C, Fagard R, Forette F: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354. |
| 338 ） | Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension（STOP-Hypertension）. Lancet 1991; 338: 1281-1285. |
| 339 ） | MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412. |
| 340 ） | SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program（SHEP）. JAMA 1991; 265: 3255-3264. |
| 341 ） | Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de-Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764. |
| 342 ） | Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China（Syst-China）Collaborative Group: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-1829. |
| 343 ） | Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V, Ghadirian P, LeLorier J, Hamet P: Shanghai trial of nifedipine in the elderly（STONE）. J Hypertens 1996; 14: 1237-1245. |
| 344 ） | Insua JT, Sacks HG, Lau TS, Lau J, Reitman D, Pagano D, Chalmers TC: Drug treatment of hypertension in the elderly: A meta-analysis. Ann Intern Med 1994; 121: 355-362. |
| 345 ） | Gueyffier F, Bulpitt C, Boissel J-P: Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Lancet 1999; 353: 793-796. |
| 346 ） | Ogihara T, Kuramoto K: Effect of long-term treatment with antihypertensive drugs on quality of life of elderly patients with hypertension: a double-blind comparative study between-calcium antagonist and a diuretic. NICS-EH study. Hypertens Res 2000; 23: 33-37. |
| 347 ） | Ogihara T on behalf of the PATE-Hypertension Study Group in Japan: A practitioner's trial on the efficacy of antihypertensive treatment in the elderly hypertension（The PATE-Hypertension Study）in Japan. Am J Hypertens 2000; 13: 461-467. |
| 348 ） | Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GR, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ: A comparison of outcomes with angiotensin converting enzyme inhibitors and diuretics in the elderly（The Second Australian National Blood Pressure Study）. N Engl J Med 2003; 348: 583-592. |
| 349 ） | Black HR, Elliott WJ, Weber MA, Frishman WH, Strom JA, Liebson PR, Hwang CT, Ruff DA, Montoro RR, DeQuattro V, Zhang D, Schleman MM, Klibaner MI, for the Stage I Systolic Hypertension（SISH）study group: One-year study of felodipine or placebo for stage I isolated systolic hypertension. Hypertension 2001; 38: 1118-1123. |
| 350 ） | Hakala SM, Tilvis RS, Strandberg TE: Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Aging Study. Eur Heart J 1997; 18: 1019-1023. |
| 351 ） | 荻原俊男，森本茂人，中橋毅，島本和明，松本正幸，大内尉義，松岡博昭，日和田邦男，藤島正敏：本邦における老年者高血圧に対する治療方針に関する検討. 日老医誌 1994; 31: 396-403. |
| 352 ） | August P: Initial treatment of hypertension. N Engl J Med 2003; 348: 610-616. |
| 353 ） | Ogihara T, Hiwada K, Morimoto S, Matsuoka H, Matsumoto M, Takishita S, Shimamoto K, Shimada K, Abe I, Ouchi Y, Tsukiyama H, Katayama S, Imai Y, Suzuki H, Kohara K, Okaishi K, Mikami H: Guidelines for treatment of hypertension in the elderly 2002 revised version. Hypertens Res 2003; 26: 1-36. |
| 354 ） | Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WB, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL, for the Systolic Hypertension in the elderly program（SHEP）cooperative research group: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program（SHEP）. JAMA 2000; 284: 465-471. |
| 355 ） | Kjeldsen SE, Kolloch RE, Leonetti G, Mallion J-M, Zanchetti A, Elmfeldt D, Qarnold I, Hansson L, for the HOT Study Group: Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. J Hypertens 2000; 18: 629-642. |
| 356 ） | Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB: The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999; 159: 2004-2009. |
| 357 ） | 日和田邦男，荻原俊男，松本正幸，松岡博昭，瀧下修一，島本和明，鳥羽研二，阿部功，小原克彦，森本茂人，三上洋，岩井邦充，高崎幹裕，河野雄平，東浦勝浩，神崎恒一，江頭正人，藤島正敏：老年者の高血圧治療ガイドライン-1999年改訂版-．日老医誌 1999; 36: 576-603. |
| 358 ） | Messerli FH, Grossman E, Golgbourt U: Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279: 1903-1907. |
| 359 ） | Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, Wester PO, Hedner T, de Faire U: Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in old patients with hypertension-2 study. Lancet 1999; 354: 1751-1756. |
| 360 ） | Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe（Syst-Eur）trial. Lancet 1998; 352: 1347-1351. |
| 361 ） | 蔵本築：老年者高血圧とACE阻害薬-Captopril二重盲検試験964例の年齢別検討．内科 1991; 68: 862-867. |
| 362 ） | 荻原俊男，日和田邦男，松岡博昭，松本正幸，島本和明，大内尉義，阿部功，藤島正敏：老年者の高血圧治療ガイドライン，1995（長寿科学総合研究班 試案）．日老医誌 1996; 33: 945-975. |
| 363 ） | Ogihara T, Arakawa K: Clinical efficacy and tolerability of candesartan cilexetil. J Hum Hypertens 1999; 13（Suppl 1）: S27-S31. |
| 364 ） | Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H, for the LIFE study group: Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. JAMA 2002; 288: 1491-1498. |
| 365 ） | Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B, on behalf of the ELITE II investigators: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582-1587. |
| 366 ） | Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ: for the CONVINCE research group: Principal results of the controlled onset verapamil investigation of cardiovascular end points（CONVINCE）trial. JAMA 2003; 289: 2073-2082. |
| 367 ） | Yamamoto Y, Sonoyama K, Matsubara K, Furuse M, Yatsuhashi T, Hamada T, Ogino K, Igawa O, Hisatome I, Shigemasa C: The status of hypertension management in Japan in 2000. Hypertens Res 2002; 25: 717-725. |
| 368 ） | Katayama S, Inaba M, Morita T, Awata T, Shimamoto K, Kikkawa R: Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertens Res 2000; 23: 601-605. |
| 369 ） | Taler SJ, Textor SC, Augustine JE: Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 2002; 39: 982-988. |
| 370 ） | Ohta Y, Tsuchihashi T, Fujii K, Matsumura K, Ohya Y, Uezono K, Abe I, Iida M: Improvement of blood pressure control in a hypertension clinic: a 10-year follow-up study. J Hum Hypertens 2004; 18: 273-278. |
| 371 ） | Ono A, Fujita T: Factors relating to inadequate control of blood pressure in hypertensive outpatients. Hypertens Res 2003; 26: 219-224. |
| 372 ） | Nishizaka MK, Zaman MA, Calhoun DA: Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003; 16: 925-930. |
| 373 ） | Kaplan NM: Hypertensive crises. In: Clinical Hypertension（8th ed.）. Lippincott Williams & Wilkins, Baltimore, 2002, pp339-356. |
| 374 ） | Vaughan CJ, Delanty N: Hypertensive emergencies. Lancet 2000; 356: 411-417. |
| 375 ） | Sesoko S, Akema N, Matsukawa T, Kaneko Y: Predisposing factors for the development of malignant essential hypertension. Arch Intern Med 1987; 147: 1721-1724. |
| 376 ） | Ohta Y, Tsuchihashi T, Ohya Y, Fujii K, Hirakata H, Abe I, Fujishima M: Trends in the pathophysiological characteristics of malignant hypertension. Hypertens Res 2001; 24: 489-492. |
| 377 ） | Kawazoe N, Eto T, Abe I, Takishita S, Uneno M, Kobayashi K, Uezono K, Muratani H, Kimura Y, Tsuchihashi T, Onoyama K, Kawasaki T, Fukiyama K, Omae T, Fujishima M: Long-term prognosis of malignant hypertension; difference between underlying diseases such as essential hypertension and chronic glomerulonephritis. Clin Nephrol 1988; 29: 53-57. |
| 378 ） | Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery）. Circulation 2002; 105: 1257-1267. |
| 379 ） | Little JW: The impact on dentistry of recent advances in the management of hypertension. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 591-599. |
| 380 ） | Tsuchihashi T, Takata Y, Kurokawa H, Miura K, Maruoka Y, Kajiyama M, Fujishima M: Blood pressure response during dental surgery. Hypertens Res 1996; 19: 189-194. |
| 381 ） | Rosenthal T, Oparil S: Hypertension in women. J Hum Hypertens 2000; 14: 691-704. |
| 382 ） | Sato K: New Proposal for hypertension in pregnancy. Nippon Ninnsin Cyuudoku 2003; 11: 15-44. |
| 383 ） | Wallenburg HC: Prevention of pre-eclampsia: status and perspectives 2000. Eur J Obstet Gynecol Reprod Biol 2001; 94: 13-22. |
| 384 ） | Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-185. |
| 385 ） | Roberts JM, Pearson G, Cutler J, Lindheimer M: Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003; 41: 437-445. |
| 386 ） | Lewis R, Sibai BM: The use of calcium-channel blockers in pregnancy. New Horiz 1996; 4: 115-122. |
| 387 ） | Shotan A, Wiiderhorn J, Hurst A, Elkayam U: Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96: 451-456. |
| 388 ） | NMWR: Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy-United States, Canada, and Israel, 1987-1995. JAMA 1997; 277: 1193-1194. |
| 389 ） | Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, Curhan G, Colditz GA, Stampfer MJ: Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996; 94: 483-489. |
| 390 ） | Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S: Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1712. |
| 391 ） | Staessen JA, Celis H, Fagard R: The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998; 12: 587-592. |
| 392 ） | Pines A, Fisman EZ: Hypertension in menopausal women-a special case, for special treatment? Gynecol Endocrinol 2001; 15: 397-405. |
| 393 ） | Fisman EZ, Tenenbaum A, Pines A: Systemic hypertension in postmenopausal women: a clinical approach. Curr Hypertens Rep 2002; 4: 464-470. |
| 394 ） | Uchiyama M: Studies of blood pressures in school children in Northern Japan. Public Health 1985; 99: 18-22. |
| 395 ） | Muntner P, He J, Cutler JA, Wildman RP, Whelton PK: Trends in blood pressure among children and adolescents. JAMA 2004; 291: 2107-2113. |
| 396 ） | Dillon MJ: Clinical aspects of hypertension. In: Pediatric Nephrology. edited by Holliday MA, Williams & Wilkins, Baltimore, 1987, pp743-757. |
| 397 ） | McCrory WW: Definition, prevalence, and distribution of causes of hypertension. In: Pediatric and adolescent Hypertension. edited by Loggie JMH, Blackwell Scientific Publications, Cambridge, 1992, pp104-111. |
| 398 ） | National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576. |
| 399 ） | 村田光範：高血圧．小児科臨床 1986; 39（増刊号）: 2977-2984. |
| 400 ） | Hashimoto N, Kawasaki T, Kikuchi T, Uchiyama M: Criteria of normal blood pressure and hypertension in Japanese preschool children. J Hum Hypertens 1997; 11: 351-354. |
